Biotech Investors & VC Firms in Israel
77 firms in this list, with a median first check of $850K. 4 of them lead rounds. Generated from verified public data and updated continuously.
GV (Google Ventures)
Mountain ViewSeed–Late Stage
34 people
Pitango
Tel AvivPre-Seed–Late Stage$2M – $40M
41 people
Norwest Venture Partners
Palo AltoGrowth
2 people
Celesta Capital
San MateoSeed–Late Stage
7 people
M Ventures
Los AngelesSeed–Series A$10.8M
11 people
Remiges Ventures, Inc.
SeattlePre-Seed–Seed
21 people
Israel Cleantech Ventures
IsraelPre-Seed–Series A$500K – $3.5M
7 people
Samsung Ventures
Menlo ParkSeed–Late Stage
22 people
Triventures
Tel AvivPre-Seed–Series A$3M
10 people
Decacorn Capital
SingaporeSeed–Series B$300K – $600K
12 people
Vertex Ventures China
SingaporePre-Seed–Late Stage
6 people
Georgian
Toronto, OntarioSeries B–Late Stage$25M – $100M
11 people
Orbia Ventures
Mexico CitySeed–Growth$1M – $6M
5 people
Vertex Ventures HC
San FranciscoSeed–Growth$500K – $10M
5 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
11 people
EQT Life Sciences
AmsterdamSeries A–Late Stage$10.8M – $64.8M
11 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$500K – $50M
11 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
MCI Capital S.A.
WarsawGrowth$27M – $108M
11 people
Stray Dog Capital
LeawoodPre-Seed–Series A
3 people
dsm-firmenich Venturing
MaastrichtPre-Seed–Late Stage$108K – $5.4M
9 people
Arkin Capital
HerzliyaSeed–Late Stage
11 people
Panakes Partners
MilanSeed–Late Stage
11 people
Serendipity Impact VC
New YorkSeed–Series B
5 people
Related lists
Crypto & Web3 Investors & VC Firms (3510)Investors & VC Firms in United States (2654)SaaS Investors & VC Firms (1994)Enterprise Software Investors & VC Firms (1791)Fintech Investors & VC Firms (1455)Healthtech Investors & VC Firms (1333)Consumer Investors & VC Firms (1247)Biotech Investors & VC Firms (1141)Data & Infrastructure Investors & VC Firms (1088)SaaS Investors & VC Firms in United States (1064)
Data sourced from public filings and firms' own websites — see our methodology.










